The daily check-in is deliberately short — a handful of questions, under a minute most days. That was a direct decision after early testing showed anything longer stopped getting filled out consistently, which made the data useless for the clinicians reading it.
What it’s actually looking for is change, not a full symptom inventory every day: anything new, anything worse, anything that should move your next review up sooner than scheduled. A short check-in that gets answered honestly is worth more than a long one that gets skipped.